Malte Maria Sieren1, Andre Nowak1, Nicolas Kirschke1, Joachim Graessner2, Hendrik Kooijman3, Joerg Barkhausen1, Alex Frydrychowicz1, and Thekla Helene Oechtering1
1Department of Radiology and Nuclear Medicine, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany, 2Siemens Healthcare GmbH, Hamburg, Germany, 3Philips GmbH, Hamburg, Germany
Synopsis
Before introduction into clinical
routine 4D Flow MRI has to be tested in larger scale studies. For data to meet
quality standards for these studies various potential error sources have to be
addressed. The aim of this study was to provide a comprehensive inter-scanner,
inter-vendor, inter-individual cross-over evaluation of a 4D Flow sequence. The
thoracic aorta of eight volunteers was examined on two 3T MRI-Scanners of
different vendors and analyzed by two readers using three different software.
While there was no significant difference between readers and MRI scanners,
differences between analysis-software where beyond clinically acceptable
limits.
Purpose
4D Flow MRI has become more and more recognized
by clinicians to assess pathology (1, 2). However, prior to being fully introduced
into clinical routine, further studies are necessary, e.g. to define threshold
values for quantitative parameters and develop dedicated protocols. Next to
inherent limitations regarding the underlying sequence, various other potential
sources of errors with regard to inter-scanner and inter-vendor repeatability
have to be addressed (3, 4). Moreover, a plethora of commercially
available software solutions, each relying on different approaches to process
4D Flow data, is available to extract quantitative flow and velocity information
as well as anatomical detail from each scan. Consistency and comparability of
data is fundamental to meet quality standards for the execution of larger-scale
studies. However, available comparative data are scarce.
Hence, the aim of this study was to provide a comprehensive
evaluation by performing an inter-scanner, inter-vendor, inter-individual
cross-over comparison to assess quantitative results of a 4D Flow sequence on
two 3T MRI scanners using three different analysis software tools.
Methods
Eight healthy volunteers (“Vol”, 3f, age 27±3) were
examined on two 3T MRI-scanners of different vendors (MRI1: Ingenia, Philips;
MRI2: Skyra, Siemens) with a retrospectively ECG-gated 4D Flow sequence. Imaging
parameters were chosen as closely matching as possible following the consensus
guidelines provided elsewhere (5) and checked with each vendor’s application
specialist. Typical imaging parameters on both scanners were: Venc=200cm/s;
vendor-specific parallel imaging with an acceleration factor of two in
phase-encoding direction; spatial resolution was kept constant inter-individually
and was 2.2-2.5mm interpolated to 2.0mm in all spatial directions. Data were
reconstructed to 24 time frames. Depending on the heart rate (49-87/min), an
effective temporal resolution of 32-58ms was achieved.
Data were assessed by two readers
blinded to each others’ results. The following software tools were used: SW1=GTFlow (v3.1.13, Gyrotools, CH), SW2=cvi42 (v5.9.2, Circle Cardiovascular Imaging, CAN), SW3=CAAS (v5.0, Pie Medical Imaging, NL) to extract flow, velocity, and
anatomical parameters such as forward and net stroke volumes (SVfw [ml],
SVnet [ml], respectively), peak flow (Qmax [ml/s]),
maximum velocity (Vmax [cm/s]), and maximum area (Amax [mm2])
on six predefined contours at reproducible anatomical landmarks as illustrated
in Fig. 1.Results
Acquisitions were performed in 18±4min (MRI1) and 12±2min (MRI2),
p<0.05. The MRI exam of a single volunteer could not be processed with SW2
and was therefore excluded. In total, both
readers analyzed 96 contours for each software. There was no significant difference in
between readers and MRI scanners for all quantitative parameters (p=n.s.).
Results of the inter-software comparison are summarized in table 1. As
opposed to the inter-scanner comparison, using different software tools resulted
in high average and relative differences. These were most notable for Vmax
and Amax. When analyzed with S3 Bland-Altman analysis revealed an
overestimation of Vmax compared to SW 1 and SW 2 (Vmax:
BA [SW1-SW3]: 42±53cm/s=54±40%; BA [SW1-SW2]: 19±61cm/s=29±34%; BA [SW2-SW3]:
26±26cm/s=30±35%, all p<0.05). SW3 also produced generally higher
values for Amax, these differences were most pronounced in
comparison between SW2 and SW3 (Vmax:
BA [SW1-SW3]: 95±108cm/s=16±20%, p=n.s.; BA [SW1-SW2]: 89±186cm/s=22±22%; BA [SW2-SW3]:
115±146cm/s=21±19%, both p<0.05). SW2 had a systematic tendency to
underestimate values versus the other software, these differences reached
statistical significance for all parameters. Relative
differences between SVfw, SVnet and Qmax did
not surpass a limit of 15% for all software.Conclusion
The inter-scanner and inter-reader results indicate a sound and
exchangeable basis for 4D Flow MR exams and seem well-suited for multi-center
studies. Regarding the inter-scanner comparison, subtle differences are
difficult to attribute to a single technical issue and are most likely the sum
of limitations known to influence 4D Flow MRI. However, care must be taken when
using or comparing results of
different software tools used for quantification. Although all software was fed
the same data, error and spread of results are beyond acceptable limits. Possible
error source inherent to the study protocol may be the generalized
reconstruction to 24 time frames, therefore not achieving optimized temporal
resolution for each volunteer. Differences
for Amax may be indicating contouring errors, affecting other
quantitative parameters. Anyway, these results call for further standardization
and normalization with respect to data format and quantification of 4D Flow MRI
data.Acknowledgements
No acknowledgement found.References
1. Jarvis
K, Vonder M, Barker AJ, et al. Hemodynamic evaluation in patients with transposition
of the great arteries after the arterial switch operation: 4D flow and 2D phase
contrast cardiovascular magnetic resonance compared with Doppler
echocardiography. J Cardiovasc Magn Reson 2016;18(1):59.
2. Reiter U, Reiter G, Fuchsjager M. MR
phase-contrast imaging in pulmonary hypertension. Br J Radiol
2016;89(1063):20150995.
3. Jarvis K, Schnell S, Barker AJ, et al.
Caval to pulmonary 3D flow distribution in patients with Fontan circulation and
impact of potential 4D flow MRI error sources. Magn Reson Med 2018.
4. Gatehouse PD, Rolf MP, Graves MJ, et
al. Flow measurement by cardiovascular magnetic resonance: a multi-centre
multi-vendor study of background phase offset errors that can compromise the
accuracy of derived regurgitant or shunt flow measurements. J Cardiovasc Magn
Reson 2010;12:5.
5. Dyverfeldt P, Bissell M, Barker AJ, et
al. 4D flow cardiovascular magnetic resonance consensus statement. J Cardiovasc Magn Reson 2015;17:72.